Pulmonx CORP Form 4 insider transactions

NASDAQ
Rose Geoffrey Beran, Chief Commercial Officer of Pulmonx Corp, sold 1,184 shares of common stock at $8.71 per share on May 22, 2024, according to a Form 4 filing.
NASDAQ
Chief Financial Officer of Pulmonx Corp, Mehul Joshi, reports the acquisition of restricted stock units and stock options.
NASDAQ
Chief Commercial Officer of Pulmonx Corp, Rose Geoffrey Beran, sold 1,184 shares of common stock at $7.49 per share on April 22, 2024, according to a Form 4 filing.
NASDAQ
Rose Geoffrey Beran, Chief Commercial Officer of Pulmonx Corp, sold 1,184 shares of common stock at a price of $9.36 per share on March 22, 2024, according to a Form 4 filing with the SEC.
NASDAQ
Steven S. Williamson, CEO of Pulmonx Corp, reports the acquisition of restricted stock units and stock options.
NASDAQ
An amended SEC filing reveals corrections to the number of shares underlying employee stock options and restricted stock units (RSUs) previously reported by Pulmonx Corp's Chief Commercial Officer, Rose Geoffrey Beran.
NASDAQ
John McKune, Interim CFO of Pulmonx Corp, files an amendment to a previous Form 4 to correct typographical errors related to the number of shares underlying employee stock options and restricted stock units (RSUs).
NASDAQ
David Aaron Lehman, General Counsel of Pulmonx Corp, files an amendment to a previous SEC Form 4 to correct errors in the reported number of shares related to employee stock options and restricted stock units.
NASDAQ
Chief Commercial Officer of Pulmonx Corp, Rose Geoffrey Beran, reports the sale of common stock to cover tax obligations and the acquisition of restricted stock units and stock options.
NASDAQ
Interim CFO of Pulmonx Corp, John McKune, reports the acquisition and disposal of common stock and stock options.
NASDAQ
General Counsel David Aaron Lehman of Pulmonx Corp reports the sale of common stock to cover tax obligations and the acquisition of restricted stock units and stock options.
NASDAQ
Pulmonx Corp CEO Glendon E. French III sold shares of common stock on March 1, 2024, to cover tax withholding obligations related to vesting Restricted Stock Units.